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A positive feedback loop between RIP3 and JNK
controls non-alcoholic steatohepatitis
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Abstract
Non-alcoholic fatty liver disease (NAFLD) represents the most
common liver disease in Western countries and often progresses to
non-alcoholic steatohepatitis (NASH) leading ultimately to liver
fibrosis and liver cancer. The occurrence of hepatocyte cell death
—so far characterized as hepatocyte apoptosis—represents a
fundamental step from benign steatosis toward progressive
steatohepatitis. In contrast, the function of RIP3-dependent
necroptosis in NASH and NASH-induced fibrosis is currently
unknown. We show that RIP3 is upregulated in human NASH and
in a dietary mouse model of steatohepatitis. RIP3 mediates liver
injury, inflammation, induction of hepatic progenitor cells/acti-
vated cholangiocytes, and liver fibrosis through a pathway
suppressed by Caspase-8. This function of RIP3 is mediated by a
positive feedback loop involving activation of Jun-(N)-terminal
Kinase (JNK). Furthermore, RIP3-dependent JNK activation
promotes the release of pro-inflammatory mediators like MCP-1,
thereby attracting macrophages to the injured liver and further
augmenting RIP3-dependent signaling, cell death, and liver fibro-
sis. Thus, RIP3-dependent necroptosis controls NASH-induced liver
fibrosis. This pathway might represent a novel and specific target
for pharmacological strategies in patients with NASH.
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Introduction
Non-alcoholic fatty liver disease (NAFLD) is the most common
chronic liver disease in the Western world (Vernon et al, 2011). The
term non-alcoholic steatohepatitis (NASH) defines a more aggres-
sive disease entity within the spectrum of NAFLD that is often asso-
ciated with obesity, type 2 diabetes, and the metabolic syndrome
(Schattenberg & Schuppan, 2011). In NASH, advanced fibrosis and
cirrhosis are primary determinants of an increased overall and liver-
related mortality (Schuppan & Afdhal, 2008; Bhala et al, 2011; Poel-
stra & Schuppan, 2011), underlining that pharmacological inhibition
of liver fibrogenesis or induction of fibrosis regression is a funda-
mental goal in this disease (Schattenberg & Schuppan, 2011).
Despite several molecular targets that were addressed in NASH
patients in recent clinical trials (Schuppan & Kim, 2013), no effec-
tive pharmacological strategy against NASH-induced liver fibrosis
has yet entered clinical practice, highlighting the need to identify
novel-signaling pathways regulating the transition from NASH to
hepatic fibrosis.
One fundamental difference between benign steatosis and
progressive steatohepatitis is the occurrence of massive hepatocyte
cell death, at present classified as hepatocyte apoptosis (Wree et al,
2013). Apoptosis can be triggered by ligation of death receptors like
tumor necrosis factor (TNF) receptor by their cognate ligands and
represents a highly synchronized procedure depending on activation
of aspartate-specific proteases known as caspases (Chakraborty
et al, 2012). Of these, Caspase-8 represents a key upstream caspase
that engages to the death-inducing signaling complex (DISC) via the
adaptor molecule FADD (Chakraborty et al, 2012). NASH is histo-
logically characterized by hepatocyte apoptosis and varying degrees
of fibrosis in the setting of hepatocyte lipid accumulation (Schatten-
berg & Schuppan, 2011). In line with this observation, previous
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functional studies in animal models and clinical studies have
focused on the potential role of apoptosis in NASH development
(Witek et al, 2009; Anstee et al, 2010; Ratziu et al, 2012; Hatting
et al, 2013). However, necrosis and necro-inflammation are also
histological characteristics of human NASH (Malhi & Gores, 2008;
Schattenberg & Schuppan, 2011), suggesting that alternative cell-
death forms might play a role in the pathogenesis of this disease. It
was recently discovered that necroptosis—programmed necrosis
depending on the kinases RIP1 and RIP3—represents an alternative
programmed cell-death pathway downstream of the TNF receptor
(Cho et al, 2009; He et al, 2009; Zhang et al, 2009). RIP3 mediates
necroptosis through activation of mixed lineage kinase domain-like
protein (MLKL) (Sun et al, 2012). Necroptosis plays a role in the
regulation of chronic inflammation in the pancreas, gut, and skin
(He et al, 2009; Bonnet et al, 2011; Welz et al, 2011). Moreover,
necroptosis is activated in patients with alcoholic liver injury
(Roychowdhury et al, 2013), but the role of RIP3 in NASH is
currently unknown.
To examine the functional role of RIP3 in NASH development,
we applied the methionine- and choline-deficient (MCD) diet-
induced model of steatohepatitis that mimics important features of
human NASH, including the development of steatohepatitis, CYP2E1
overexpression, and increased lipid peroxidation as well as the
promotion of NASH toward hepatic fibrosis (Schattenberg et al,
2006). In addition, most previous data on the relation between cell
death and NASH were gained in this respective model (Csak et al,
2011; Hatting et al, 2013). We show that RIP3 controls NASH devel-
opment in a Caspase-8-dependent manner by a pathway involving
activation of Jun-(N)-terminal kinase and thus might represent a
promising target for future therapeutic strategies in patients with
chronic metabolic liver disease.
Results
RIP3 mediates liver injury in MCD-diet-induced NASH
In order to examine the differential functions of RIP3-dependent
necroptosis versus Caspase-8-dependent apoptosis in NASH, we
generated mice with conditional deletion of Caspase-8 in liver paren-
chymal cells (LPC)—hepatocytes and cholangiocytes—(Casp-8LPC-KO),
constitutive ablation of Rip3 in all cells (RIP3!/!), and mice with
combined conditional and constitutive deletions of Caspase-8 and
RIP3, respectively (Casp-8LPC-KO/RIP3!/!) (Supplementary Fig S1).
These groups of mice were treated for either 2 or 8 weeks with
MCD-diet or normal chow as control and were first analyzed for the
degree of liver injury. As described previously (Vucur et al, 2013),
Casp-8LPC-KO mice showed a moderate increase in serum levels of
aspartate aminotransferase (AST) and glutamate dehydrogenase
(GLDH) but not alanine aminotransferase (ALT) in mice fed with
normal chow (Fig 1A). After 2 and 8 weeks of MCD-diet, serum
levels of AST, ALT, and GLDH were increased in all groups
compared to the respective control animals on normal chow
(Fig 1A). Strikingly, enzyme levels were more increased in Casp-
8LPC-KO animals at both time points compared to all other experi-
mental groups (Fig 1A). In contrast, after 8 weeks of MCD-diet, all
liver enzymes were reduced in RIP3!/! mice and Casp-8LPC-KO/
RIP3!/! animals compared to WT mice (Fig 1A). Together, these
findings indicate that RIP3 mediates liver injury upon MCD-diet
feeding in mice.
Based on this observation, we further examined intrahepatic
expression levels of RIP3 in this model. It was previously shown
that necroptotic cell death in the liver or pancreas is associated with
an increase in RIP3 protein levels (He et al, 2009; Vucur et al,
2013). In line, 2 weeks of MCD-diet feeding led to a strong induction
of RIP3 protein levels in Western blot analysis (Fig 1B). Of note, this
induction of RIP3 expression was even augmented in Casp-8LPC-KO
animals with abrogated Caspase-8-expression (Fig 1B), while—as
expected—no RIP3 expression was detected in Casp-8LPC-KO/RIP3!/!
and RIP3!/! livers (Fig 1B). Immunohistological analyses of livers
of mice after 8 weeks of MCD-diet feeding confirmed high expres-
sion levels of RIP3 in WT mice and even stronger expression in
Casp-8LPC-KO livers (Fig 1C and D). In contrast, immunohistological
staining for cleaved Caspase-3 revealed similarly low levels of
cleaved Casp-3+ hepatocytes in all groups (Supplementary Fig S2).
The fact that cleavage of Caspase-3 was also detected in mouse
livers with conditional deletion of Caspase-8 indicated that apop-
tosis in this model can be activated by Caspase-8-independent
signaling cascades, e.g. via the mitochondrial pathway (Estaquier
et al, 2012). In line with this finding, it was previously shown that
in NASH, fatty acid accumulation enhances b-oxidation and mito-
chondrial electron overflow, thus triggering cell death (Seifert et al,
2010). Finally, compensatory proliferation of parenchymal liver cells
measured by staining for Ki67 correlated with overexpression of
RIP3 and was most prominent in Casp-8LPC-KO mice, while Casp-
8LPC-KO/RIP3!/! and RIP3!/! mice showed significantly less prolif-
erating cells than MCD-diet-fed WT mice (Fig 1C and D). Together,
these observations demonstrate that activation of RIP3 represents a
fundamental step in the MCD-diet NASH model mediating liver
injury. Moreover, a crucial function of Caspase-8 in this model is to
counterbalance RIP3-dependent liver injury.
RIP3 controls the transition from NASH to liver fibrosis in a
Caspase-8 dependent manner
Based on the differential functions of RIP3 and Caspase-8 in control-
ling liver injury in response to MCD-diet feeding, we next tested
their influence on the pathogenesis of steatosis and NASH-induced
liver fibrosis. Hematoxylin and eosin (H&E) staining revealed mini-
mal steatosis in all groups of mice after 8 weeks of normal chow
feeding (Fig 2A). Of note, mice with combined deletions of Caspase-
8 and Rip3 (Casp-8LPC-KO/RIP3!/! mice) on normal chow already
displayed increased triglyceride (TG) levels compared to the other
experimental groups (Fig 2B). Eight weeks of MCD-diet feeding trig-
gered hepatic fat accumulation above control levels in all groups
(Fig 2A and B). In line with the control groups, MCD-diet feeding
led to significantly higher intrahepatic TG contents in Casp-8LPC-KO/
RIP3!/! mice compared to all other experimental groups, suggesting
that inactivation of both programmed cell-death pathways augments
hepatic fat accumulation in the MCD-diet model.
The presence of apoptosis in NAFLD patients has been taken as a
predictor to develop progressive fibrosis (Witek et al, 2009; Anstee
et al, 2010; Ratziu et al, 2012). In contrast, while necrosis is also
found as histological characteristic in human NASH (Malhi & Gores,
2008; Schattenberg & Schuppan, 2011), the functional relation to
fibrosis is presently poorly defined. We therefore investigated
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the correlation between the occurrence of liver fibrosis and the
activation of necroptosis in the MCD-diet model. Sirius red staining
and qRT-PCR analysis for Collagen-1a1 expression after 2 weeks
(Supplementary Fig S3) and 8 weeks of MCD-diet feeding (Fig 2C
and D) revealed no significant liver fibrosis at the early time points
and moderate fibrosis at the later time point in WT animals. In
contrast, correlating with induction of RIP3 expression levels, Casp-
8LPC-KO animals displayed strongly increased intrahepatic fibrosis at
both time points, whereas hepatic fibrogenesis was strongly reduced
in RIP3!/! single-mutant mice and Casp-8LPC-KO/RIP3!/! double-
mutant animals compared to WT and Casp-8LPC-KO mice (Fig 2C and
D; Supplementary Fig S3). These data indicate that RIP3-dependent
necroptosis promotes NASH-induced liver fibrosis. Moreover, acti-
vation of Caspase-8 inhibits RIP3-dependent liver fibrosis in NASH.
We have further addressed the question whether the previously
shown pro-fibrogenic effect of RIP3 is specific for liver fibrosis in
response to hepatic steatosis or represents a general principle in
hepatic fibrogenesis. To test this, we used an alternative, very well-
established model of experimental liver fibrosis relying on repetitive
injections of the substance CCl4 into mice and applied this model for
2 and 6 weeks to WT, Casp-8LPC-KO, Casp-8LPC-KO/RIP3!/!, and
RIP3!/! mice. This treatment led to the development of areas of
parenchymal cell necrosis in Casp-8LPC-KO mice (Supplementary Fig
S4). However, it did not result in a significantly increased degree of
fibrosis between the groups of mice in quantitative analysis of Sirius
Red staining (Supplementary Fig S4), supporting the hypothesis that
RIP3 might represent a specific target in fatty liver-related liver
fibrosis.
RIP3-activation in NASH promotes inflammation and hepatic
recruitment of monocytes/macrophages
Inflammation represents a fundamental factor linking liver injury
with hepatic fibrosis (Tacke et al, 2008; Schuppan & Kim, 2013).
We therefore examined the association between liver fibrosis and
inflammation in response to necroptosis upon MCD-diet feeding. As
assessed by immunohistochemistry, 8 weeks of MCD-diet feeding
increased the number of infiltrating CD45+ immune cells in all
experimental groups of mice compared to WT mice fed with normal
chow. Of note, inflammation was even higher in Casp-8LPC-KO mice
and correlated with the strong expression of RIP3 as the number of
CD45+ immune cells was reduced to WT levels in Casp-8LPC-KO/
RIP3!/! mice and RIP3!/! animals (Fig 3A and B). We next
investigated the impact of infiltrating monocytes, which play a pro-
fibrogenic role in different experimental models of liver fibrosis as
well as human liver disease (Zimmermann & Tacke, 2011). As
A B
C D
Figure 1. RIP3 is induced in murine livers following MCD-diet feeding and promotes hepatic injury in Caspase-8-deficient livers.
A Analysis of serum levels of AST, ALT, and GLDH after 2 and 8 weeks of MCD-diet or 2 weeks of normal chow. Results are shown as mean " SEM, n = 6 (2 weeks
normal chow) n = 12 (2 weeks MCD), and n = 5 (8 weeks MCD). §indicates that serum levels are significantly increased from basal level.
B Western blots analysis on liver extracts from MCD-diet-fed (2- and 8-weeks) animals and control mice with antibodies against RIP3, Caspase-8, and GAPDH as a
loading control.
C Immunohistochemical (RIP3, Ki67) analysis on representative liver sections from the indicated mice fed for 8 weeks with MCD-diet.
D Statistical analysis of RIP3+ and Ki67+ hepatocytes. Results are shown as mean, n = 5. §indicates that RIP3+ and Ki67+ cells are significantly increased from basal WT
group.
Data information: The exact P-values of each experiment and specific tests used are provided in the Supplementary Table S1.
Source data is available online for this figure.
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demonstrated by immunohistochemistry, 8 weeks of MCD-diet
feeding significantly increased the number of inflammatory foci
containing monocytes in WT mice and even more in Casp-8LPC-KO
livers (Fig 3A and B). In contrast, the emergence of these foci was
completely abrogated by the deletion of Rip3 as seen in Casp-8LPC-KO/
RIP3!/! and RIP3!/! animals (Fig 3A and B). The activation role of
RIP3 in the initiation of inflammation was confirmed by FACS
analyses in livers of mice fed for 2 weeks with MCD-diet, revealing
significantly lower numbers of F4/80+ cells in Casp-8LPC-KO/RIP3!/!
mice and RIP3!/! animals than seen in Casp-8LPC-KO mice (Sup-
plementary Fig S5). Taken together, these results indicate that RIP3-
dependent inflammation and recruitment of monocytes represents
an important mechanism for promoting hepatic fibrosis in mice fed
with MCD-diet.
We further tested which inflammatory mediators might be
involved in linking necroptosis of parenchymal liver cells with
monocyte recruitment and increased hepatic fibrosis. Interestingly,
while many inflammatory cytokines and chemokines such as Inter-
leukin (IL)-1a, IL-1b, IL-6, CCL1 and CCL8, and CCL17 did not show
a clearly distinct regulation between WT and Casp-8LPC-KO mice fed
for 2 weeks with MCD-diet on mRNA level (Supplementary Fig S6),
qRT-PCR analysis and FACS-based microbeads fluorescence assay
on liver extracts from the different experimental groups revealed a
strong increase in intrahepatic levels of MCP-1 (CCL2) in Casp-8LPC-KO
mice compared to WT mice at that time point (Fig 3C). In
contrast, MCP-1-levels were markedly reduced in Casp-8LPC-KO/
RIP3!/!, and RIP3!/! mice (Fig 3C), which was confirmed after
8 weeks of MCD-diet feeding (Fig 3D). Given previous reports on
the essential functional role of the MCP-1/CCR2 axis in monocyte
recruitment and liver fibrosis (Seki et al, 2009; Baeck et al, 2012),
these data indicate that MCP-1 represents one important factor link-
ing RIP3-dependent necroptosis in NASH with liver fibrosis. Further
analyses revealed increased TNF levels in WT and Casp-8LPC-KO
mice after 8 weeks of MCD feeding, as well as a strong correlation
between RIP3 expression levels and levels of TGF-b2 (Supplemen-
tary Fig S7), which is in line with a recent report showing a promi-
nent role of TGF-b in the regulation of NASH-associated hepatocyte
cell death (Yang et al, 2014).
The alfp-cre line used to generate Casp-8LPC-KO animals mediates
genetic excision exclusively in liver parenchymal cells (LPC) (Kel-
lendonk et al, 2000), arguing for a specific function of RIP3 in this
respective cell compartment in driving liver injury and subsequent
fibrogenesis in Casp-8LPC-KO mice upon MCD-diet feeding. However,
in order to exclude that constitutive deletion of Rip3 in Casp-8LPC-KO/
RIP3!/! mice resulted in general signaling defects of immune cells
as a reason for the rescue of these double-mutant animals from
hepatic fibrosis, we isolated and cultured monocytes from murine
bone marrow of WT, Casp-8LPC-KO, Casp-8LPC-KO/RIP3!/!, and
RIP3!/! mice. Stimulation with lipopolysaccharide (LPS) resulted
in very similar patterns of chemokine and cytokine expression
A B
DC
Figure 2. RIP3-dependent necroptosis promotes NASH-induced liver fibrosis and inflammation.
A Representative H&E staining of liver slides from 16-week-old WT, Casp-8LPC-KO, Casp-8LPC-KO/RIP3!/!, and RIP3!/! mice fed for 8 weeks with normal chow (upper
panel) or MCD-diet (lower panel).
B Intrahepatic triglycerides levels in WT, Casp-8LPC-KO, Casp-8LPC-KO/RIP3!/!, and RIP3!/! fed for 8 weeks with MCD-diet or control chow, results are shown as
mean " SEM, n = 5 per group. §indicates that triglycerides are significantly increased from Casp-8LPC-KO/RIP3!/! to the others groups of mice fed with normal chow.
C Representative Sirius Red stainings of liver slides from 8-week-old female WT, Casp-8LPC-KO, Casp-8LPC-KO/RIP3!/!, and RIP3!/! mice fed for 8 weeks with MCD-diet.
D Left: statistical quantification of light polarized Sirius Red pictures, results are shown as mean, n = 5 per group. Right: Col1a1 mRNA levels in these livers were
determined by qRT-PCR. Values were calculated relative to WT mice fed with normal show, and b-catenin was used as an internal standard, n = 5 per group.
§indicates that values are significantly increased from basal level. Error bars represent SEM.
Data information: The exact P-values of each experiment and specific tests used are provided in the Supplementary Table S1.
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(Supplementary Fig S8), suggesting that the functional activity of macro-
phages is not abrogated in RIP3!/! and Casp-8LPC-KO/RIP3!/! mice.
RIP3-expression in murine and human NASH livers
Most liver diseases and also NASH—once advanced—develop into a
portal fibrosis with proliferation of biliary progenitors and activated
cholangiocytes, which typically form small clusters and non-
functional biliary structures (Richardson et al, 2007; Schuppan &
Kim, 2013). We therefore tested the relation between RIP3-dependent
necroptosis and a biliary ductular reaction in the MCD-diet model.
Strikingly, immunostaining for Cytokeratin (CK)-19 revealed a
strong expansion of clusters of biliary cells / progenitor cells in
livers of Casp-8LPC-KO mice, which was not seen in combined or
single RIP3-mutants (Fig 4A and B). Of note, immunostaining for
RIP3 and specific analysis in areas of ductular reactions revealed
that many cholangiocytes expressed even higher levels of RIP3 than
the surrounding hepatocytes (Fig 4C).
It was previously demonstrated in liver samples from human
NASH patients that RIP3 is strongly upregulated on RNA level to
more than 40-fold compared to healthy controls (Csak et al, 2011).
In order to provide further evidence for a function of RIP3 in human
NASH, we examined RIP3 expression in livers of NASH patients (as
demonstrated histologically by increased NAS score, see Fig 5A) by
Western blot and immunohistochemistry. On protein levels, RIP3
was strongly upregulated in NASH patients compared to controls
(Fig. 5B). Immunostaining of NASH patient livers revealed strong
RIP3 expression in hepatocytes, often neighboring areas of fat depo-
sition (Fig 5C). Of note, RIP3 often showed a granule-like staining
pattern (Fig 5C), similar to previous imaging results in MEF cells
with activated RIP3 signaling depicting clustering of RIP1/RIP3 (Li
et al, 2012). Finally, RIP3 was often overexpressed in cells morpho-
logically reflecting cholangiocytes / bile duct cells (Fig 5C), similar
to our previous findings in mouse livers. These findings support the
hypothesis that also in human NASH, liver cells are sensitized to
necroptotic cell death. Moreover, in murine as well as human
A B
DC
Figure 3. RIP3-dependent necroptosis promotes NASH-induced liver fibrosis through MCP-1 release.
A Immunohistochemical analysis of CD45 (upper panel) and F4/80 (middle panel) on representative liver sections from the indicated mice fed for 8-weeks with MCD-
diet or normal chow. The lower panel shows deconvoluted pictures from the F4/80 stains.
B Statistical analysis of CD45+ and F4/80+ cells. Results are shown as mean, n = 5. §indicates that F4/80+ foci are significantly increased from basal WT group.
C Left: MCP-1 mRNA levels were assessed by RT-PCR after 2 weeks of MCD-diet feeding. Values were calculated relative to WT mice fed with normal chow, and b-
catenin was used as an internal standard, n = 6 per group. Right: FACS-based microbeads fluorescence assay for MCP-1 expression in liver protein homogenates.
Results are shown as mean, n = 6 per group. § shows that values are significantly increased from basal level. Error bars indicate SEM.
D Left: MCP-1 mRNA levels were assessed by RT-PCR after 8 weeks of MCD-diet feeding. Values were calculated relative to WT mice fed with normal chow, and b-
catenin was used as an internal standard, n = 5 per group. §indicates that values are significantly increased from basal level. Error bars represent SEM. Right: FACS-
based microbeads fluorescence assay for MCP-1 expression in liver protein homogenates. Results are shown as mean, n = 5 per group. §shows that values are
significantly increased from basal level. Error bars indicate SEM.
Data information: The exact P-values of each experiment and specific tests used are provided in the Supplementary Table S1.
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NASH, biliary cells express high levels of RIP3, pointing toward cell-
type specific functions of this pathway in the liver.
A positive feedback loop involving activation of Jun-(N)-terminal
Kinase (JNK) mediates RIP3-dependent inflammation and hepatic
fibrosis upon MCD feeding
We finally aimed at further evaluating which potential downstream
pathway mediated RIP3-dependent liver injury, inflammation, and
fibrosis upon MCD feeding. To test this, we first examined the acti-
vation status of stress-related signaling cascades in the different
knockout models after 2 weeks of MCD-diet feeding. As shown by
Western blot analysis using phospho-specific antibodies, increased
activation of RIP3 and fibrosis upon MCD-diet feeding correlated
with increased phosphorylation and activation of the kinase Jun-
(N)-terminal Kinase (JNK) in WT and even more in Casp-8LPC-KO
livers (Fig 6A), which was abolished in Casp-8LPC-KO/RIP3!/! and
RIP3!/! mice (Fig 6A). In contrast, activation of AKT and p38a did
not show a clear association with the activation status of RIP3
(Fig 6A).
Given previous reports on the crucial function of JNK in the
mediation of NASH fibrosis (Schattenberg et al, 2006), we further
examined the functional role of JNK in RIP3-dependent NASH fibro-
sis and treated groups of Casp-8LPC-KO mice with repetitive injections
of the well-established JNK-inhibitor SP600125 or vehicle substance
as control in parallel to MCD-diet feeding. This treatment resulted in
effective inhibition of phosphorylation of the JNK-target c-Jun
(Fig 6B). JNK inhibition significantly ameliorated liver injury as
shown by decreased levels of serum aminotransferases and
GLDH in SP600125-treated mice (Fig 6C). In line, JNK inhibition
ameliorated liver fibrosis as shown by Sirius Red staining and qRT-
PCR analysis for expression of Collagen-Ia1 (Fig 6D). Moreover,
decreased fibrosis in these livers went along with reduced intrahe-
patic numbers of CD45+ and F4/80+ cells (Fig 6E), correlating with
reduced levels of MCP-1 (Supplementary Fig S9). Interestingly,
immunostaining and Western blot analysis revealed that inhibition
of JNK during MCD-diet feeding significantly reduced expression
levels of RIP3 in parenchymal liver cells (Fig 6F and G). To further
confirm a mutual interaction between RIP3 and JNK signaling, we
used L929 cells and confirmed that these cells undergo necroptosis
upon stimulation with the pan-Caspase-inhibitor zVAD (Supplemen-
tary Fig S10). Of note, additional treatment with the necroptosis
inhibitor Nec-1 (Degterev et al, 2013) and also with SP600125 abol-
ished zVAD-induced cell death. Moreover, JNK inhibition was asso-
ciated with reduced RIP3 expression levels (Supplementary Fig
S10). These data suggest that activation of JNK in LPC and probably
non-parenchymal cells (NPC) further augments hepatic RIP3 signal-
ing in terms of a positive feedback loop.
Discussion
For years, the term apoptosis, describing a form of cell death
depending on the activation of caspases, was used synonymously
for programmed cell death (Najimi et al, 2009). Apoptotic death of
hepatocytes is a common feature of non-alcoholic steatohepatitis,
and it was shown that both extrinsic and intrinsic apoptotic
pathways are involved in NASH-induced hepatocyte death
(Feldstein et al, 2003; Feldstein & Gores, 2005). Apoptosis has been
considered as a driving force of NASH-induced liver fibrosis
A
B C
Figure 4. RIP3-dependent necroptosis mediates expansion of progenitor cells that expressed high levels of RIP3.
A Immunohistochemical (CK19) analysis on representative liver sections from the indicated mice fed for 8-weeks with MCD-diet.
B Statistical analysis of CK19+ cells. Results are shown as mean, n = 5. §shows that CK19+ cells are significantly increased from basal WT group.
C Immunohistochemical (RIP3) analysis on representative liver sections from WT and Casp-8LPC-KO mice fed for 8 weeks with MCD-diet.
Data information: The exact P-values of each experiment and specific tests used are provided in the Supplementary Table S1.
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(Chakraborty et al, 2012), as it promotes activation of hepatic stel-
late cells to hepatic myofibroblasts, promoting deposition of extra-
cellular matrix and scar formation in the liver (Chakraborty et al,
2012). Biomarkers of apoptosis like Cytokeratin-18 are strongly
increased in NASH patients and distinguish between simple steato-
sis and NASH (Wieckowska et al, 2006; Younossi et al, 2008).
Finally, the paradigmatic concept of apoptosis in NASH fibrosis has
led to translational approaches into clinical studies, testing the use
of apoptosis inhibitors in NASH patients (Ratziu et al, 2012).
Recently, however, it became evident that next to apoptosis,
“necroptosis” represents an alternative programmed cell-death
pathway (Han et al, 2011). Here, we demonstrate for the first time
that RIP3-dependent necroptosis represents an important regulatory
pathway driving the transition from NAFLD to NASH and subse-
quent liver fibrosis. Therefore, this pathway might represent a
promising novel target for therapeutic strategies in NASH. More-
over, in contrast to previous assumptions (Hatting et al, 2013), our
findings indicate that the main function of Caspase-8 in the MCD-
NASH model is to counterbalance the deleterious hyperactivation of
RIP3-dependent necroptosis, underlining the mutual inhibitory
functions of RIP3 and Caspase-8 that were previously demonstrated,
for example in embryonic development (Kaiser et al, 2011) and
skin homeostasis (Weinlich et al, 2013).
The relevance of apoptosis for NASH progression is supported by
several studies. As such, it was clearly demonstrated that usage of
the pan-Caspase-inhibitor VX-166 significantly reduced liver injury
and liver fibrosis in MCD-diet-fed db/db mice (Witek et al, 2009).
However, pan-caspase inhibitors inhibit numerous caspases includ-
ing the downstream executioner caspases. In addition, chemical
pan-caspase inhibitors act also on Caspase-1, which mediates prote-
olytic cleavage of Interleukin molecules including IL-1b (Chang &
Yang, 2000; Das et al, 2009). Given recent data that specific inhibi-
tion of Caspase-1 inhibits NASH fibrosis (Dixon et al, 2013), it is
possible that targeting of this respective pathway might also contrib-
ute to the beneficial effects of pan-caspase inhibitors in NASH fibro-
sis. Moreover, our finding that also in Caspase-8-deficient livers
apoptosis of hepatocytes is detected on a low level upon MCD-diet
feeding suggests that Caspase-8-independent apoptosis are primarily
activated in the MCD-diet model, which is supported by the fact that
Casp-8LPC-KO/RIP3!/! mice still showed significant liver injury in
this respective model. Taken together, our present study together
with previous findings indicate that both programmed cell-death
A B
C
Figure 5. RIP3 is overexpressed in livers of human NASH patients.
A Western blot analysis of RIP3 in control livers (n = 4) and human NASH patients (n = 10), using antibodies against RIP3, cleaved Caspase-3, and GAPDH as a loading
control.
B NAS scores of control livers and human NASH samples, corresponding to the Western blot analysis for RIP3.
C Immunostaining analyses of RIP3 in control livers and human NASH patients (P1, P2, P3) (blue arrows indicate progenitor/biliary cells, black arrows indicate necrotic
hepatocytes, red arrows show clusters of RIP3 in hepatocytes, and yellow arrows indicate inflammatory cells grouped around dying hepatocytes). Pictures are
representative for 27 samples examined.
Source data are available online for this figure.
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pathways—(Caspase-8-independent) apoptosis and necroptosis—are
involved in the pathogenesis of NASH and NASH-induced liver fibro-
sis. Of note, the degree of steatosis in our different genetically modi-
fied mouse models did not strictly correlate with the extent of liver
injury upon MCD-diet feeding. Instead, blockage of both cell-death
pathways (necroptosis and Caspase-8-dependent apoptosis) in Casp-
8LPC-KO/RIP3!/! mice resulted in an increase in intrahepatic fat accu-
mulation in this model compared with WT or single-mutant animals,
suggesting that absence of these two programmed cell-death path-
ways might increase the tolerance of hepatocytes to store lipids with-
out undergoing cell death. Alternatively, given that multiple
molecular interactions between programmed cell-death pathways
and autophagy have been suggested (Pattingre et al, 2005; Yousefi
et al, 2006), simultaneous inhibition of Caspase-8-dependent apopto-
sis and necroptosis might alter the activity of cellular pathways
controlling lipolysis in hepatocytes (Liu & Czaja, 2013).
Our present findings diverge from a previous publication show-
ing reduced liver damage in the MCD-diet model upon Caspase-8-
deletion in hepatocytes (Hatting et al, 2013). It is important to note
that in our study, we used the alfp-cre line (Kellendonk et al, 2000)
that mediates highly efficient deletion of floxed genes at an early
developmental time point in all parenchymal liver cells including
cholangiocytes and progenitor cells, while in contrast, in the previ-
ous study, the albumin-cre (alb-cre) line was used (Postic et al,
1999). Of note, comparison of RIP3-expression levels between alfp-
cre/Caspase-8Fl and alb-cre/Caspase-8Fl confirmed high RIP3
expression upon alfp-cre-mediated Caspase-8 deletion (Supplemen-
tary Fig S11), which is in line with previous reports on Caspase-8
deletion in other organs like skin (Weinlich et al, 2013). In contrast,
we did not detect RIP3 upregulation upon albumin-cre-mediated
deletion, further supporting the association between RIP3 expres-
sion levels and necroptotic liver injury.
In our experiments, we identified the stress-activated kinase JNK
as a prominent mediator of RIP3-dependent liver injury and fibro-
genesis in the MCD-diet model. Moreover, we show that mutual
interactions exist between JNK- and RIP3-activation, as chemical
inhibition of JNK not only ameliorated liver injury and fibrosis
downstream of RIP3, but also led to reduced expression levels of
RIP3 in liver parenchymal cells (LPC). Importantly, it is presently
not clear whether the striking effect of chemical JNK inhibition in
our model was mediated through JNK inhibition in hepatocytes or
rather in non-parenchymal liver cells (NPLC). Previous data using
conditional JNK-knockout mice in the Concanavalin-A model of
hepatitis suggested that JNK activation in NPLC but not in LPC
represents a major control mechanism in the regulation of hepatitis
(Das et al, 2009). Hence, it is possible that JNK activation in LPC
promotes RIP3-dependent liver injury through generation of inflam-
matory cytokines, which in turn augments RIP3 expression and acti-
vation in LPC. However, our experiments in L929 cells suggest that
a cell-autonomous or intercellular feedback loop exists in hepato-
cytes between RIP3- and JNK-signaling. Further experiments with
conditional JNK-knockout mice are needed to functionally clarify
the cell-specific relation between RIP3 and JNK in vivo.
Another prominent finding in our study was the strong, RIP3-
dependent induction of biliary cells in the MCD-diet model. Acti-
vated cholangiocytes are related, if not identical to biliary progenitor
cells (Schuppan & Kim, 2013). These cells can proliferate in
response to hepatocyte growth arrest or cell death and were shown
to secrete factors that attract and activate hepatic stellate cells for
ECM deposition (Richardson et al, 2007; Schuppan & Kim, 2013).
Moreover, biliary cells were previously suggested to be more resis-
tant to oxidative stress and cell death than hepatocytes (Richardson
et al, 2007). Thus, their expansion in Casp-8LPC-KO mice might
reflect a biliary regenerative response in a context of necroptotic
hepatocytes, but might also represent a functional amplification
loop in the mediation of RIP3-dependent liver fibrosis upon NASH.
Interestingly, our findings indicated that biliary cells seemed to
express high levels of RIP3 compared to hepatocytes, a finding
currently lacking a functional explanation. It is possible that, given
their putative resistance to cell death (Schuppan & Kim, 2013), bili-
ary or precursor cells might tolerate higher levels of RIP3 in the
absence of functional Caspase-8 before undergoing cell death.
Future experiments with bile duct-specific cre-lines could also reveal
a previously unrecognized role of RIP3 or Caspase-8 in biliary
homeostasis, regeneration, or the intercellular communication
between biliary cells and hepatocytes.
We have recently shown that Caspase-8-dependent apoptosis but
not RIP3-dependent necroptosis promoted liver fibrosis and hepato-
carcinogenesis in a model of liver injury caused by conditional dele-
tion of the kinase TGF-b-activated Kinase-1 (Tak1) in parenchymal
liver cells (Vucur et al, 2013). In this light, our present findings
showing a protective function of Caspase-8 and an injury-promoting
role of RIP3 are opposing their roles in the TAK1 model, indicating
that activation modes and outcomes of distinct programmed cell
death-forms depend on the initiating stimulus and pathogenic
context. Given that chemical apoptosis inhibitors have already been
tested in clinical studies in patients with NASH (Ratziu et al, 2012),
pharmacological targeting of the necroptosis pathway might poten-
tially have additive beneficial effects in a combinatory approach
together with apoptosis inhibitors that do not specifically target
Caspase-8 in these patients. In addition, previous studies showed
that serum parameters reflecting activation of apoptosis might serve
as biomarkers in NASH (Chakraborty et al, 2012). Therefore,
enhanced activation of necroptosis could serve as an indicator for
more progressive liver disease, which should be evaluated in future
prospective studies.
Materials and Methods
Study approval
All animal experiments were approved by the Federal Ministry for
Nature, Environment and Consumers’ Protection of the state of
North Rhine-Westphalia and were performed in accordance to the
respective national, federal, and institutional regulations.
Generation of conditional knockout mice
Mice carrying loxP-site-flanked (floxed) alleles of the Caspase-8-gene
(Caspase-8 fl) (Salmena et al, 2003) were crossed to alfp-cre trans-
genic mice (Kellendonk et al, 2000) to generate a liver parenchymal
cell (LPC)-specific knockout (Caspase-8LPC-KO). Mice with constitu-
tive deletion of RIP3 (RIP3!/!) were described before (Newton et al,
2004). Mice with double knockout of conditional deletion of
Caspase-8 and constitutive ablation of Rip3 (Caspase-8LPC-KO/RIP3!/!)
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were generated by intercrossing the respective lines. Alb-Cre
Caspase-8Floxed transgenic mice were described previously (Hatting
et al, 2013). In all experiments, littermates carrying the respective
loxP-flanked alleles but lacking expression of Cre recombinase were
used as wild-type (WT) controls. Mice were bred on a C57BL/6
genetic background. Only sex-matched animals were compared.
Animal experiments
Mice were fed with a methionine choline-deficient (MCD) diet (MP
Biomedicals) for 2 weeks (short term) or 8 weeks (long term).
Livers from these mice were collected, fixed in 4% PFA, and embed-
ded in paraffin for histological evaluation. Intraperitoneal injection
of the JNK-Inhibitor SP600125 (15 ll/1 mg) (Absource Diagnostics)
or vehicle (DMSO) was performed twice a day over 2 weeks of MCD
feeding.
Human liver tissue
Human liver biopsy specimens and clinicopathological data were
obtained from Newcastle upon Tyne University / Hepatopancreato-
biliary and Gastroenterology Research Tissue Bank and Essen Univer-
sity. The project was authorized by the local ethics committees and
conducted in accordance with the ethical standards laid down in the
Declaration of Helsinki (Newcastle and North Tyneside 1 Research
Ethics Committee, Newcastle upon Tyne, Reference number 10/
10906/41 and Research Ethics Committee, Essen University, Refer-
ence number 09-4252). Histological scoring system for non-alcoholic
fatty liver disease (NAFLD) was performed according to the NAS
score system (Kleiner et al, 2005).
Serum analysis
Serum ALT, AST, and GLDH activities were measured by standard
procedures in the Institute of Clinical Chemistry of the RWTH
University Hospital Aachen.
Triglyceride assay
The intrahepatic triglyceride tenor was measured by TG liquicolor
mono (Human Diagnostics) according to the manufacturer’s instruc-
tions from homogenized frozen liver sample.
Western blot analysis
Liver tissue was homogenized in NP-40 lysis buffer using a tissue
grind pestle (Kimble/Chase) to obtain protein lysates. These were
separated by SDS–polyacrylamide gel electrophoresis (PAGE), trans-
ferred to PVDF membrane, and analyzed by immunoblotting.
Membranes were probed with the following antibodies: anti p-AKT,
anti p-ERK, anti p-JNK, anti p-p38 (Cell Signaling), anti-Caspase-8
(Enzo), anti-RIP3 (IMGENEX) and anti-GAPDH (ABD Serotec). As
secondary antibodies, anti-rabbit-HRP and anti-mouse-HRP (Amer-
sham) were used.
Flow cytometry
Multicolor staining was conducted using combinations of the follow-
ing mAbs: F4/80 (Serotec), CD11b (eBioscience), CD45, and Ly6G
(BD). Flow cytometric analysis was performed on a FACS-Canto II
(BD). Absolute cell numbers were determined by adding 2 × 104
Calibrite APC beads (BD) to each sample before measurement as
internal reference standard. Data were analyzed using FlowJo soft-
ware (Tree Star). For measurement of MCP-1 in total liver protein
extracts, we used the mouse FlowCytomix kit (eBioscience) accord-
ing to the manufacturer’s instructions using a FACSCanto II System
(BD).
Histological examination
Paraffin sections (2 lm) were stained with H/E or various primary
and secondary antibodies. Paraformaldehyde (4%)-fixed and paraf-
fin-embedded liver tissue were incubated in Bond Primary antibody
diluent (Leica), and staining was performed on a BOND-MAX immu-
nohistochemistry robot (Leica Biosystems) using BOND polymer
refine detection solution for DAB. The following antibodies were
used: Antibodies against F4/80 (BMA Biomedicals AG, 1:120), anti-
CD45 (BD, 1:200) anti-CK19 (TROMAIIIc, Hybridoma bank, 1:500),
anti-Ki67 (NeoMarkers; 1:200), anti-cleaved Caspase-3 (Cell Signal-
ing; 1:300), anti-phospho c-Jun (Abcam, 1:100), and anti-RIP3
(Enzo, 1:500). Image acquisition was performed on an Olympus
BX53 microscope with a Leica SCN400 slide scanner. The number of
hepatocytes positively stained for the different nuclear markers
(e.g. Ki67, pc-Jun) was determined using SlidePath TissueIA image
analysis software (Leica) on whole tissue sections (paraffin embed-
Figure 6. RIP3 mediates MCD-diet-induced NASH and liver fibrosis through activation of Jun-(N)-terminal kinase (JNK).
A Western blot analysis of whole liver protein extracts from WT, Casp-8LPC-KO, Casp-8LPC-KO/RIP3!/!, and RIP3!/! mice fed with MCD-diet for 14 days, using antibodies
against the phosphorylated and active forms of JNK, AKT, p38 and GAPDH, JNK, AKT, and p38 as loading controls.
B Immunohistochemical (left) and statistical analysis (right) of nuclear p-c-Jun+ hepatocytes on representative liver sections from Casp-8LPC-KO mice treated with
SP600125 or vehicle (DMSO) for 2 weeks under MCD-diet, n = 6 per group.
C Analysis of serum levels of AST, ALT, and GLDH of vehicle-treated and SP600125-treated mice after 2 weeks of MCD-diet feeding. Results are shown as mean " SEM,
n = 6 per group.
D Left: representative Sirius Red stainings of mice treated with vehicle substance (DMSO) or SP600125 for 2 weeks. Right: Col1a1 mRNA levels quantification by qRT-
PCR, n = 6 per group. Error bars represent SEM.
E Immunohistochemical (left) and statistical analysis (right) of CD45+ and F4/80+ cells on representative liver sections from Casp-8LPC-KO mice treated with SP600125 or
vehicle (DMSO) for 2 weeks with MCD-diet, n = 6 per group.
F Immunostaining analysis of RIP3 in Casp-8LPC-KO mice treated with SP600125 or vehicle (DMSO) for 2 weeks with MCD-diet.
G Western blot analysis of RIP3 in Casp-8LPC-KO mice treated with SP600125 or vehicle (DMSO) for 2 weeks with MCD-diet.
Data information: The exact P-values of each experiment and specific tests used are provided in the Supplementary Table S1.
Source data are available online for this figure.
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ded) and normalized to tissue area or hepatocyte number, respec-
tively. Hepatocytes positively stained for cleaved Caspase-3 and
RIP3 as well as macrophages positive for F4/80, immune cells posi-
tively stained for CD45 or MHCII, and fibrotic fibers stained with
Sirius Red were quantified numerically (positive cells per total tissue
area) or densitometrically (area stained per total tissue area) using
SlidePath TissueIA image analysis software (Leica) on whole tissue
sections and normalized to total tissue area.
Cell culture
L929 cells were cultured in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal calf serum, penicillin (100 IU/ml),
streptomycin (0.1 mg/ml), and L-glutamine (0.03%). Bone marrow
cells were isolated from femur and tibia of 8-week-old C57BL6/J and
RIP3!/! mice. To obtain fibroblast-conditioned medium (FCM)
which is known to contain the macrophage colony-stimulating factor
(MCSF, CSF1), L929 fibroblasts were cultured in RPMI medium
containing 10% fetal calf serum (FCS) for 3 days, and the superna-
tant was collected, filtered, and stored until usage at !80°C. For the
generation of bone marrow derived macrophages (BMM), bone
marrow cells were cultured in RPMI medium containing 10% FCS
and 20% FCM for 1 week on bacterial grade plastic plates (Greiner).
At day 7, cells were either left untreated or stimulated for additional
24 h with lipopolysaccharides (LPS, 1 lg/ml) (Sigma-Aldrich).
Analysis of cell survival
L929 cells were cultured overnight in 12-well plates and used at
50% of confluence. After pre-treatment with zVAD (20 lM) (Milli-
pore) for 1 h, the cells were incubated with Necrostatin-1 (10 lM)
(Santa Cruz), SP600125 (20 lM) (Absource), or DMSO as control.
Nineteen hours later, the cells were incubated with 1 ng/ml of MTT
reagent (Life Technologies) for 2 h. Once MTT crystals were devel-
oped and controlled under light microscopy, they were dissolved in
DMSO and quantified by measuring absorbance at 540 nm.
Quantitative real-time PCR
Total RNA was purified from liver tissue using TRIzol reagent (Invi-
trogen) and an RNeasy Mini kit (Qiagen). The quantity and quality
of the RNA were determined spectroscopically using a nanodrop
(Thermo Scientific). Total RNA (1 lg) was used to synthesize cDNA
using the Transcriptor cDNA First-Strand Synthesis Kit (Roche)
according to the manufacturer’s protocol and was resuspended in
50 ll of H2O. cDNA samples (2 ll) were used for real-time PCR in a
total volume of 25 ll using SYBR Green Reagent (Invitrogen) and
specific primers on a qPCR machine (Applied Biosystems 7300
Sequence Detection System). All real-time PCRs were performed in
duplicates. Data were generated and analyzed using SDS 2.3 and
RQ manager 1.2 software. Primer sequences are available upon
request. All values were normalized to the level of beta-actin
mRNA.
Statistical analysis
Data were analyzed using PRISM software (GraphPad, Inc., La Jolla,
CA) and are expressed as SEM. Statistical significance between
experimental groups was assessed using unpaired two-sample t-test,
Mann–Whitney test, and unpaired two-sample t-test with Welch’s
correction (*P < 0.05; **P < 0.01; ***P < 0.001). The exact
P-values of each experiment and specific tests used are provided in
Supplementary Table S1.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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The paper explained
Problem
Apoptosis was previously considered as the main driver of NASH devel-
opment in patients with fatty liver disease. In this line, Caspase-8 was
suggested as a promising target for novel pharmacological strategies,
but it was unknown whether other programmed cell-death pathways
than apoptosis might be involved in the pathophysiology of NASH.
Results
We show that RIP3-dependent necroptosis represents a major driving
force mediating NASH-induced liver fibrosis. This function of RIP3 was
mediated by activation of JNK as its pharmacological inhibition
reduced intrahepatic level of RIP3 and subsequently liver fibrosis and
was associated with MCP-1-mediated recruitment of monocytes and
an expansion of intrahepatic biliary / progenitor cells. Finally, in
contrast to previous assumptions, we demonstrate that the main
function of Caspase-8 in this context is to suppress the deleterious
effect of RIP3-dependent necroptosis.
Impact
The novel RIP3/JNK axis in the liver might represent a novel pharma-
cological target and/or biomarker in the clinical context of NASH and
NASH-induced liver fibrosis. In contrast, pharmacological targeting of
Caspase-8 might have deleterious effects in NASH patients, as this
might activate necroptosis and trigger liver fibrosis.
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